Patent ID: 11919963
Assignee: INHIBRX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 17:
18. An isolated T cell comprising a polypeptide comprising at least one VHH domain that binds CD123, wherein at least one VHH domain comprises a CDR1, a CDR2, and a CDR3, respectively comprising the amino acid sequences of SEQ ID NOs: 42, 43, and 44; 3, 4, and 5; 7, 8, and 9; 7, 8, and 38; 11, 12, and 13; 15, 16, and 17; 19, 20, and 21; 23, 24, and 25; or 23, 94, and 25.